Emergent BioSolutions Inc (EBS)
2.04
+0.18
(+9.68%)
USD |
NYSE |
Apr 19, 16:00
2.06
+0.02
(+0.98%)
After-Hours: 20:00
Emergent BioSolutions Accounts Payable (Quarterly): 112.20M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 112.20M |
September 30, 2023 | 112.70M |
June 30, 2023 | 108.30M |
March 31, 2023 | 124.20M |
December 31, 2022 | 103.50M |
September 30, 2022 | 103.80M |
June 30, 2022 | 106.20M |
March 31, 2022 | 107.30M |
December 31, 2021 | 128.90M |
September 30, 2021 | 135.20M |
June 30, 2021 | 151.80M |
March 31, 2021 | 142.20M |
December 31, 2020 | 136.10M |
September 30, 2020 | 102.80M |
June 30, 2020 | 84.80M |
March 31, 2020 | 84.20M |
December 31, 2019 | 94.80M |
September 30, 2019 | 91.30M |
June 30, 2019 | 124.50M |
March 31, 2019 | 78.60M |
December 31, 2018 | 80.70M |
September 30, 2018 | 38.87M |
June 30, 2018 | 41.63M |
March 31, 2018 | 46.22M |
December 31, 2017 | 41.80M |
Date | Value |
---|---|
September 30, 2017 | 30.11M |
June 30, 2017 | 29.60M |
March 31, 2017 | 27.18M |
December 31, 2016 | 34.65M |
September 30, 2016 | 46.34M |
June 30, 2016 | 58.97M |
March 31, 2016 | 45.61M |
December 31, 2015 | 37.97M |
September 30, 2015 | 41.25M |
June 30, 2015 | 41.82M |
March 31, 2015 | 40.58M |
December 31, 2014 | 40.93M |
September 30, 2014 | 39.35M |
June 30, 2014 | 36.97M |
March 31, 2014 | 36.64M |
December 31, 2013 | 27.52M |
September 30, 2013 | 29.02M |
June 30, 2013 | 25.71M |
March 31, 2013 | 23.87M |
December 31, 2012 | 31.30M |
September 30, 2012 | 27.35M |
June 30, 2012 | 23.30M |
March 31, 2012 | 28.32M |
December 31, 2011 | 40.53M |
September 30, 2011 | 33.90M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
84.20M
Minimum
Mar 2020
151.80M
Maximum
Jun 2021
113.41M
Average
108.30M
Median
Jun 2023
Accounts Payable (Quarterly) Benchmarks
Avid Bioservices Inc | 22.78M |
Viking Therapeutics Inc | 7.512M |
FibroGen Inc | 17.96M |
Avinger Inc | 0.777M |
RAPT Therapeutics Inc | 5.176M |